These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8291508)
1. Sotalol: a new agent for the treatment of ventricular arrhythmias. Samoil D; Grubb BP; Temesy-Armos PN Am J Med Sci; 1994 Jan; 307(1):49-53. PubMed ID: 8291508 [TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic actions of DL-sotalol in ventricular and supraventricular arrhythmias. Singh BN J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S75-90. PubMed ID: 1279313 [TBL] [Abstract][Full Text] [Related]
4. Sotalol: a novel beta-blocker with class III anti-arrhythmic activity. Leibowitz D J Clin Pharmacol; 1993 Jun; 33(6):508-12. PubMed ID: 8366175 [TBL] [Abstract][Full Text] [Related]
6. Sotalol: from "just another beta blocker" to "the prototype of class III antidysrhythmic compound". Claudel JP; Touboul P Pacing Clin Electrophysiol; 1995 Mar; 18(3 Pt 1):451-67. PubMed ID: 7770366 [TBL] [Abstract][Full Text] [Related]
7. Sotalol: a new beta-adrenergic blocker for ventricular arrhythmias. Cavusoglu E; Frishman WH Prog Cardiovasc Dis; 1995; 37(6):423-40. PubMed ID: 7777671 [TBL] [Abstract][Full Text] [Related]
8. Concentration/response relations for the multiple antiarrhythmic actions of sotalol. Woosley RL; Barbey JT; Wang T; Funck-Brentano C Am J Cardiol; 1990 Jan; 65(2):22A-27A; discussion 35A-36A. PubMed ID: 2294688 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents. Singh BN Am J Cardiol; 1993 Aug; 72(4):8A-18A. PubMed ID: 8346731 [TBL] [Abstract][Full Text] [Related]
10. D-Sotalol: death by the SWORD or deserving of further consideration for clinical use? Doggrell SA; Brown L Expert Opin Investig Drugs; 2000 Jul; 9(7):1625-34. PubMed ID: 11060766 [TBL] [Abstract][Full Text] [Related]
11. Clinical experience with sotalol in the treatment of cardiac arrhythmias. Kirschenbaum HL; Rosenberg JM Clin Ther; 1994; 16(3):346-64. PubMed ID: 7923303 [TBL] [Abstract][Full Text] [Related]
12. Sotalol: An important new antiarrhythmic. Anderson JL; Prystowsky EN Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618 [TBL] [Abstract][Full Text] [Related]
13. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias. Fitton A; Sorkin EM Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652 [TBL] [Abstract][Full Text] [Related]
14. Historical development of the concept of controlling cardiac arrhythmias by lengthening repolarization: particular reference to sotalol. Singh BN Am J Cardiol; 1990 Jan; 65(2):3A-11A; discussion 35A-36A. PubMed ID: 2403733 [TBL] [Abstract][Full Text] [Related]
17. Expanding clinical role of unique class III antiarrhythmic effects of sotalol. Singh BN Am J Cardiol; 1990 Jan; 65(2):84A-88A. PubMed ID: 2403738 [TBL] [Abstract][Full Text] [Related]
19. Sotalol: a new class III antiarrhythmic agent. Zanetti LA Clin Pharm; 1993 Dec; 12(12):883-91. PubMed ID: 8137605 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol. Advani SV; Singh BN Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]